Found: 8
Select item for more details and to access through your institution.
Recent Developments in Diagnostic and Prognostic Biomarkers for Colorectal Cancer: A Narrative Review.
- Published in:
- Oncology, 2023, v. 101, n. 10, p. 675, doi. 10.1159/000531474
- By:
- Publication type:
- Article
Lenvatinib as Second-Line Treatment after Atezolizumab plus Bevacizumab for Unresectable Hepatocellular Carcinoma: Clinical Results Show Importance of Hepatic Reserve Function.
- Published in:
- Oncology, 2023, v. 101, n. 10, p. 624, doi. 10.1159/000531316
- By:
- Publication type:
- Article
Adverse Event Profile of Azacitidine: Analysis by Route of Administration Using Japanese Pharmacovigilance Database.
- Published in:
- Oncology, 2023, v. 101, n. 10, p. 664, doi. 10.1159/000531390
- By:
- Publication type:
- Article
Front & Back Matter.
- Published in:
- Oncology, 2023, v. 101, n. 10, p. 1, doi. 10.1159/000534426
- Publication type:
- Article
Relationship between Plasma IP-10/CXCL10 Levels and the Initial Therapeutic Response in Patients Treated with Atezolizumab plus Bevacizumab for Unresectable Hepatocellular Carcinoma.
- Published in:
- Oncology, 2023, v. 101, n. 10, p. 655, doi. 10.1159/000531689
- By:
- Publication type:
- Article
Effects of Lenvatinib on Skeletal Muscle Volume and Cardiac Function in Patients with Hepatocellular Carcinoma.
- Published in:
- Oncology, 2023, v. 101, n. 10, p. 634, doi. 10.1159/000531562
- By:
- Publication type:
- Article
Intralesional Chemotherapy for Prostate Cancer: In vivo Proof of Principle.
- Published in:
- Oncology, 2023, v. 101, n. 10, p. 645, doi. 10.1159/000531494
- By:
- Publication type:
- Article
Impact of Renal Function on the Prognosis of Patients Receiving Atezolizumab/Bevacizumab Combination Therapy and Lenvatinib Monotherapy for Unresectable Hepatocellular Carcinoma.
- Published in:
- Oncology, 2023, v. 101, n. 10, p. 609, doi. 10.1159/000531111
- By:
- Publication type:
- Article